APA (7th ed.) Citation

Stiehler, S., Sembill, S., Schleicher, O., Marx, M., Rauh, M., Krumbholz, M., . . . Metzler, M. (2024). Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort. Haematologica (Roma), 109(8), 2555-2563. https://doi.org/10.3324/haematol.2023.284668

Chicago Style (17th ed.) Citation

Stiehler, Sophie, et al. "Imatinib Treatment and Longitudinal Growth in Pediatric Patients with Chronic Myeloid Leukemia: Influence of Demographic, Pharmacological, and Genetic Factors in the German CML-PAED Cohort." Haematologica (Roma) 109, no. 8 (2024): 2555-2563. https://doi.org/10.3324/haematol.2023.284668.

MLA (9th ed.) Citation

Stiehler, Sophie, et al. "Imatinib Treatment and Longitudinal Growth in Pediatric Patients with Chronic Myeloid Leukemia: Influence of Demographic, Pharmacological, and Genetic Factors in the German CML-PAED Cohort." Haematologica (Roma), vol. 109, no. 8, 2024, pp. 2555-2563, https://doi.org/10.3324/haematol.2023.284668.